2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Sulindac: new trials by email Literature Review of Sulindac trials Research Report on Sulindac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer sulindac, laboratory biomarker analysis - Breast Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2005-11-01 | 2013-05-03 |
| Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma Erlotinib, Erlotinib plus sulindac, Placebo - Head and Neck Squamous Cell Carcinoma | Phase 1 | Completed | University of Pittsburgh | 47 | 2005-11-01 | 2023-03-28 |
Breast Carcinoma In Situ (1) · Breast Neoplasms (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Squamous Cell Carcinoma of Head and Neck (1)
National Cancer Institute (NCI) (1) · University of Pittsburgh (1)
United States (2)
Jennifer Grandis, MD (1) · Patricia Thompson, PhD (1)
P30CA023074 (1)